Φορτώνει......
Adjuvant Endocrine Therapy and Risk of Contralateral Breast Cancer among U.S. Women with Breast Cancer
IMPORTANCE: Within ten years after breast cancer diagnosis, 5% of patients develop contralateral primary breast cancer (CBC). Randomized trials have found that tamoxifen and aromatase inhibitors (AIs) reduce CBC risk. However, little is known about the magnitude and duration of protective effects wi...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | JAMA Oncol |
|---|---|
| Κύριοι συγγραφείς: | , , , , , , , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
2016
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5757540/ https://ncbi.nlm.nih.gov/pubmed/27711920 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamaoncol.2016.3340 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|